The number of major amputations done each year for vascular insufficiency is not precisely known but is probably about 10 000. This suggests that between 20% and 40% of all critically ischaemic legs are amputated eventually.
Society's attitudes to amputation have changed little since mediaeval times, and patients' responses to loss of a limb remain nearly as dramatic as to the announcement of terminal illness. Recent advances in vascular surgery have led us to reappraise the optimal management of critical leg ischaemia and in this article we consider the roles of amputation and revascularisation.
Surgical options
Most, though not all, patients with critically ischaemic legs require successful arterial reconstruction if major amputation is to be avoided. Management depends on the site of the stenosis or occlusion. Certain options are preferable at particular sites, but effective reconstruction often requires simultaneous or serial application of several techniques. en a viable limb does not confer any tage because the patient is already totally dent, however, the risk:benefit ratio is d and primary amputation may be priate.
rocrural reconstruction
Len occlusive vascular disease extends id the popliteal artery into the three crural Is (the peroneal artery and the anterior and rior tibial arteries) percutaneous techniques no value in primary revascularisation. We fore insert a femorocrural bypass graft orr-deem the disease unreconstructable and out a primary amputation. Grafts at this often fail, and the patient's morale is sapped eries of revisions followed by major itation. It is therefore in patients with distal se that we need to look closely at oarisons in outcome between modern struction and amputation ifwe are to de the patient with the best chance of ning to normal life.
Autologous vein can be harvested from the long saphenous in either leg, the short saphenous vein, or an arm vein. If a thorough search is made it is usually possible to construct a long femorocrural graft with vein, but on some occasions (particularly if there has been more than one previous operation) an adequate amount of vein cannot be found. The patency rates for vein grafts may be as high as 70% at one year and 60% at three years, but if prosthetic material is used for these long grafts the results are not nearly as good. The use of a venous collar seems to improve the patency rates of femorocrural prosthetic grafts, however, and patency rates 20% worse than those for vein grafts are now being achieved.
Mortality
Early reports of long term survival in patients who presented with critical leg ischaemia suggested a five year mortality of 40%-100% regardless of management. More recently, however, improved survival rates have been reported; up to 80% of patients may be expected to survive for three years and we must consider this when recommending treatment. Mortality 30 days after reconstruction compares favourably with that after amputation (1% compared with 10% in our current practice), and this improvement is presumably a consequence of the aggressive management of vascular disease in other areas of the body, notably the coronary circulation. Femorocrural reconstruction can therefore be undertaken safely in patients with critical leg ischaemia. This operation has implications for a large proportion of patients, most of whom will survive for some years after their operations.
Necrotic ulcer of the heel (top left): a femoroperoneal vein graft and removal of part of the calcaneus followed by skin grafting (top right) resulted in full rehabilitation (left).
Mobility
Successful reconstruction has been associated with excellent mobility; almost four fifths of patients could walk independently outside their homes. Conversely, mobility after amputation was poor with less than a third ofpatients walking independently outside their homes, and over a third being confined to a wheelchair or bed. Poor mobility after amputation has now been reported from several centres at which geriatric patients are treated, and these results have important implications for everybody concerned with the management of leg ischaemia. Limb salvage and graft patency At follow up after three years 72% of vein grafts and 51% of prosthetic grafts were still viable (97% of irreversible graft failures resulted in major amputations). Further operations to maintain the patency of the grafts was required in 15% of patients during subsequent years and they avoided amputation. These reinterventions depend on a graft surveillance programme in which stenoses in the grafts are identified by treadmill Doppler studie's, duplex scanning, or intravenous digital subtraction angiography. We rely on duplex scanning, which must be carried out twice within the first six months of operation to be of any value as almost all stenoses on grafts develop within the first year.
These patency figures were achieved in a relatively unselected group of patients in whom scrupulous attention was paid to graft follow up, correction of intragraft stenoses, correction of polycythaemia, and appropriate anticoagulation. Many ofthe patients stopped smoking because the dire consequences were so obvious, and stopping smoking is now of confirmed benefit.
Costs
Analysis of the cost of each option is now an integral part of health care. Assessment of the cost of vascular reconstruction must accommodate the primary operation and all subsequent procedures (including the cost of secondary amputation when necessary). The primary reconstruction is only one third of the cost of amputation, but when subsequent operations (including some major amputations) are also considered, the cost ofgrafting veins to distal crural vessels more than doubles. Using these grafts routinely is nevertheless cheaper than doing primary amputations. Even when the higher rates of failure and reintervention that are associated with prosthetic grafting are included, the overall cost of reconstruction is less than that of amputation.
We advise revascularisation for almost all patients who present with aortoiliac or femoropopliteal occlusive disease and limb threatening ischaemia. In addition, we now also suggest reconstruction to the distal crural vessels; this affects about one third of patients. Femorocrural bypass grafts can be inserted with a low operative mortality, and they result in vastly improved mobility compared with amputation. In addition, these grafts give acceptable rates of limb salvage and graft patency at medium term follow up (even when prosthetic grafts are used) and can be done for less than the cost of amputation.
Given most patients' undoubted objection to amputation we believe that ie revascularisation should be offered to almost all those with limb threatening ischaemia unless the patient's quality of life will -not be improved by saving the leg.
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